Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 511,451 $ 947,498
Prepaid expenses 107,926 148,660
Total current assets 619,377 1,096,158
Investments held in Trust Account 230,041,987 230,003,947
Total assets 230,661,364 231,100,105
Current liabilities:    
Accounts payable 1,329
Accrued expenses 40,000 127,000
Franchise tax payable 184,974 134,974
Total current liabilities 224,974 263,303
Deferred underwriting commissions 8,050,000 8,050,000
Derivative warrant liabilities 3,250,000 7,423,330
Total liabilities 11,524,974 15,736,633
Commitments and Contingencies
Class A common stock, $0.0001 par value; 23,000,000 shares subject to possible redemption at $10.00 per share at March 31, 2022 and December 31, 2021 230,000,000 230,000,000
Stockholders’ Deficit:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at March 31, 2022 and December 31, 2021
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; zero non-redeemable shares issued and outstanding at March 31, 2022 and December 31, 2021
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 5,750,000 shares issued and outstanding at March 31, 2022 and December 31, 2021 575 575
Additional paid-in capital
Accumulated deficit (10,864,185) (14,637,103)
Total stockholders’ deficit (10,863,610) (14,636,528)
Total Liabilities and Stockholders’ Deficit $ 230,661,364 $ 231,100,105